Create a narrative

FMC Community

NYSE:FMC Community

3 Narratives written by author
0 Comments on narratives written by author
52 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 19 Analysts

Post-Patent Rynaxypyr Mixtures And Brazil Channels Will Expand Market Reach

Key Takeaways Strategic initiatives in Brazil, direct sales and new formulations, are expected to boost revenue growth and offset price erosion, maintaining stable margins. FMC's focus on innovation with new active ingredients and low-cost manufacturing supports strong earnings growth, particularly in 2025.

US$47.69

FV

16.1% undervalued

4.95%

Revenue growth p.a.

1

0

33

5 days ago